Recent reports have linked the use of Tepezza to tinnitus (ringing in the ears) and hearing loss. There are no warnings about these potential side effects on the packaging.
Tepezza (teprotumumab-trbw) is made by Ireland-based drugmaker Horizon Therapeutics USA Inc. Tepezza is used to treat an autoimmune condition called thyroid eye disease (TED), a condition where the muscles and fatty tissues behind the eye become inflamed, causing swollen, red eyes which can lead to double vision and eye bulging. The medication is administered via intravenous infusion every three weeks.
Recent reports have linked the use of Tepezza to tinnitus (ringing in the ears) and hearing loss. There are no warnings about these potential side effects on the packaging. Tepezza (teprotumumab-trbw) is made by Ireland-based drugmaker Horizon Therapeutics USA Inc.
TED is a serious condition that affects the muscles and fatty tissue behind the eye, causing the eyes to bulge outwards and leading to double vision, pain and vision loss. Tepezza is the first FDA-approved treatment specifically for TED and is considered a breakthrough drug for this condition. However, the recent reports of tinnitus and hearing loss associated with the drug have raised concerns about its safety.
According to the FDA, the most common side effects of Tepezza include muscle spasms, nausea, and diarrhea. However, there have been reports of tinnitus and hearing loss in some patients taking the drug. The FDA has issued a warning to healthcare providers and patients about these potential side effects and has advised patients to monitor for any changes in hearing and to report any hearing loss or tinnitus to their healthcare provider.
It is important to note that the risk of tinnitus and hearing loss associated with Tepezza is still being studied. The drug was approved by the FDA in January of 2020, and the exact percentage of patients experiencing these side effects is not yet known. However, patients and healthcare providers should be aware of the potential risks and monitor for any changes in hearing. Any unusual symptoms should be reported to a healthcare provider.
If you or a loved one has experienced tinnitus or hearing loss after taking Tepezza, it is important to seek legal advice as soon as possible. Attorney Marilyn McGoldrick of Thornton Law Firm is currently investigating claims of patients who have been affected by these side effects and is offering a free consultation to anyone who has experienced tinnitus or hearing loss after taking Tepezza. Call Attorney McGoldrick at 888-491-9726 for a free consult.
In conclusion, Tepezza is a thyroid eye disease drug that is used to treat thyroid eye disease, an autoimmune condition that causes swollen, red eyes and can lead to double vision and eye bulging. However, recent reports have linked the use of Tepezza to tinnitus (ringing in the ears) and hearing loss, with no warnings about these potential side effects on the packaging. If you or a loved one has experienced hearing loss and/or tinnitus after taking Tepezza, it is important to seek legal advice as soon as possible. Do not hesitate to contact Attorney Marilyn McGoldrick at 888-491-9726 for a free consultation if you or a loved one has experienced tinnitus or hearing loss after taking Tepezza.
